Bilha Fischer

Affiliations: 
1992-1993 Bar-Ilan University, Jerusalem, Jerusalem District, Israel 
Google:
"Bilha Fischer"
Mean distance: 9.38
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Salameh H, Afri M, Gottlieb HE, et al. (2020) β-Cyanuryl Ribose, β-Barbituryl Ribose, and 6-Azauridine as Uridine Mimetics. Acs Omega. 5: 31314-31322
Nassir M, Balaom L, Fischer B. (2020) Addressing regio- and stereo-specificity challenges in the synthesis of nucleoside 2',3'-cyclic monophosphate analogs - a rapid and facile synthesis of nucleoside-2',3'-,-phosphoro-thioate or -selenoate, and elucidation of the origin of the rare specificity. Chemical Communications (Cambridge, England)
Nassir M, Mirza S, Arad U, et al. (2019) Adenine-(methoxy)-ethoxy-P-dithio-triphosphate inhibits pathologic calcium pyrophosphate deposition in osteoarthritic human chondrocytes. Organic & Biomolecular Chemistry
Nassir M, Pelletier J, Arad U, et al. (2019) Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold. European Journal of Medicinal Chemistry. 184: 111754
Pariente Cohen N, Lo Presti E, Dell'Acqua S, et al. (2019) Correction to Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by Cu(II)-Prion Peptide Complex. Inorganic Chemistry
Nassir M, Arad U, Lee SY, et al. (2019) Correction to: Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes. Purinergic Signalling
Pariente Cohen N, Lo Presti E, Dell'Acqua S, et al. (2019) Aminomethylene-Phosphonate Analogue as a Cu(II) Chelator: Characterization and Application as an Inhibitor of Oxidation Induced by the Cu(II)-Prion Peptide Complex. Inorganic Chemistry
Nassir M, Arad U, Lee SY, et al. (2019) Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuating undesired NPPase activity in human osteoarthritic chondrocytes. Purinergic Signalling
Jacob TF, Singh V, Dixit M, et al. (2018) A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist. Purinergic Signalling
Danino O, Svetitsky S, Kenigsberg S, et al. (2018) Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug. Rheumatology (Oxford, England)
See more...